• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: an updated meta-analysis of randomized placebo-controlled trials.

作者信息

Matsuda Yuki, Kishi Taro, Iwata Nakao

机构信息

Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.

出版信息

J Psychiatr Res. 2013 Dec;47(12):2018-20. doi: 10.1016/j.jpsychires.2013.09.002. Epub 2013 Sep 15.

DOI:10.1016/j.jpsychires.2013.09.002
PMID:24079776
Abstract
摘要

相似文献

1
Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: an updated meta-analysis of randomized placebo-controlled trials.N-甲基-D-天冬氨酸受体拮抗剂增效治疗精神分裂症的疗效与安全性：随机安慰剂对照试验的最新荟萃分析
J Psychiatr Res. 2013 Dec;47(12):2018-20. doi: 10.1016/j.jpsychires.2013.09.002. Epub 2013 Sep 15.
2
Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.精神分裂症的辅助性美金刚治疗：一项随机、双盲、安慰剂对照试验的荟萃分析。
Psychol Med. 2018 Jan;48(1):72-81. doi: 10.1017/S0033291717001271. Epub 2017 May 22.
3
Are NMDA receptor antagonists beneficial in the treatment of schizophrenia?N-甲基-D-天冬氨酸受体拮抗剂对精神分裂症的治疗有益吗？
J Psychiatr Res. 2014 Apr;51:19-20. doi: 10.1016/j.jpsychires.2013.12.007. Epub 2013 Dec 31.
4
NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials.NMDA 受体拮抗剂治疗精神分裂症的随机、安慰剂对照试验的荟萃分析。
J Psychiatr Res. 2013 Sep;47(9):1143-9. doi: 10.1016/j.jpsychires.2013.04.013. Epub 2013 May 18.
5
Is Memantine Effective as an NMDA-Receptor Antagonist in Adjunctive Therapy for Schizophrenia?美金刚作为 NMDA 受体拮抗剂辅助治疗精神分裂症有效吗？
Biomolecules. 2020 Jul 31;10(8):1134. doi: 10.3390/biom10081134.
6
Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.难治性精神分裂症阴性和阳性症状的改善：一项双盲、随机、安慰剂对照试验，以美金刚作为氯氮平的附加治疗。
J Clin Psychiatry. 2009 Oct;70(10):1416-23. doi: 10.4088/JCP.08m04935gry.
7
Augmentation of Antipsychotic Treatment with Memantine in Patients with Schizophrenia: A Systematic Review and Meta-Analysis.美金刚对精神分裂症患者抗精神病治疗的增效作用：一项系统评价和荟萃分析。
Turk Psikiyatri Derg. 2019 Winter;30(4):253-259.
8
[Memantine as an adjunctive therapy for schizophrenia negative symptoms].[美金刚作为精神分裂症阴性症状的辅助治疗]
Braz J Psychiatry. 2005 Sep;27(3):257-8. doi: 10.1590/s1516-44462005000300023. Epub 2005 Oct 4.
9
Efficacy of -methyl--aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials.- 甲基 -D - 天冬氨酸受体调节剂增效治疗精神分裂症的疗效：一项随机、安慰剂对照试验的荟萃分析。
J Psychopharmacol. 2021 Mar;35(3):236-252. doi: 10.1177/0269881120965937. Epub 2021 Jan 6.
10
Memantine and catatonic schizophrenia.美金刚与紧张型精神分裂症。
Am J Psychiatry. 2005 Mar;162(3):626. doi: 10.1176/appi.ajp.162.3.626.

引用本文的文献

1
Pharmacological Treatments of Negative Symptoms in Schizophrenia-An Update.精神分裂症阴性症状的药物治疗——最新进展
J Clin Med. 2024 Sep 23;13(18):5637. doi: 10.3390/jcm13185637.
2
Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia.精神分裂症阴性症状和认知功能障碍的生物学机制和治疗进展。
Neurosci Bull. 2021 Nov;37(11):1609-1624. doi: 10.1007/s12264-021-00740-6. Epub 2021 Jul 5.
3
Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia.基于精神分裂症N-甲基-D-天冬氨酸受体功能减退假说的药物
Front Neurosci. 2021 Apr 12;15:641047. doi: 10.3389/fnins.2021.641047. eCollection 2021.
4
Is Memantine Effective as an NMDA-Receptor Antagonist in Adjunctive Therapy for Schizophrenia?美金刚作为 NMDA 受体拮抗剂辅助治疗精神分裂症有效吗？
Biomolecules. 2020 Jul 31;10(8):1134. doi: 10.3390/biom10081134.
5
Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function.精神分裂症基于可塑性干预的听觉系统靶点作用：聚焦于 N-甲基-D-天冬氨酸型谷氨酸受体功能的调制。
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jul;3(7):581-590. doi: 10.1016/j.bpsc.2018.02.002. Epub 2018 Feb 22.
6
Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.精神分裂症阴性症状的治疗：全面综述。
Drugs. 2017 Sep;77(13):1423-1459. doi: 10.1007/s40265-017-0789-y.
7
Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence.42种联合药物治疗策略联合抗精神病药物单药治疗对精神分裂症的疗效：荟萃分析证据的系统综述与质量评估
JAMA Psychiatry. 2017 Jul 1;74(7):675-684. doi: 10.1001/jamapsychiatry.2017.0624.
8
Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis.美金刚联合抗精神病药物治疗精神分裂症残留阴性和认知症状的荟萃分析。
Psychopharmacology (Berl). 2017 Jul;234(14):2113-2125. doi: 10.1007/s00213-017-4616-7. Epub 2017 May 15.
9
Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.单剂量美金刚可改善精神分裂症患者的皮层振荡反应动力学。
Neuropsychopharmacology. 2017 Dec;42(13):2633-2639. doi: 10.1038/npp.2017.81. Epub 2017 Apr 20.
10
Tackling negative symptoms of schizophrenia with memantine.用美金刚治疗精神分裂症的阴性症状。
Case Rep Psychiatry. 2014;2014:384783. doi: 10.1155/2014/384783. Epub 2014 Apr 10.